Natixis Advisors
HCAT icon

Natixis Advisors’s Health Catalyst HCAT Stock Holding History

Natixis Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,736
Closed -$425K – 1440
2021
Q4 		$425K Sell
10,736
-1,614
-13% -$73.6K ﹤0.01% 1267
2021
Q3 		$618K Buy
12,350
+1,477
+14% +$80.6K ﹤0.01% 1177
2021
Q2 		$604K Buy
10,873
+792
+8% +$42.2K ﹤0.01% 1186
2021
Q1 		$471K Buy
+10,081
New +$488K ﹤0.01% 1177

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Natixis Advisors's HCAT Position: Q1 2022 in Review

Natixis Advisors sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 10,736 shares — an estimated $425K sold.

Natixis Advisors first reported a position in HCAT in Q1 2021 and held it in 4 quarters. The position peaked at $618K in Q3 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Natixis Advisors reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Natixis Advisors sold 10,736 Health Catalyst shares in Q1 2022, an estimated $425K.
  • Natixis Advisors first reported a position in Health Catalyst in Q1 2021 and held it in 4 quarters.
  • Natixis Advisors's Health Catalyst position peaked at $618K in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Natixis Advisors's 13F filing for Q1 2022, filed 12 May 2022.